长期透析患者的容量评估:现状、方法与未来方向
该综述指出,长期透析患者的容量评估存在单位间实践差异大、现有方法不完美的问题。同位素稀释法不实用,体重与血压趋势仅作替代指标,临床体征诊断准确性差,肺超声与生物电阻抗有科学依据但未在试验中证实改善结局。需通过比较效果研究、标准化容积参数测量及整合现有方法改进容量管理。
要点
- 现有容量评估方法各有局限,无理想金标准。
- 肺超声与生物电阻抗未在临床试验中证实改善临床结局。
- 需开展不同液体管理策略的比较效果研究。
核心结论
- 长期透析患者容量评估方法不完美,需系统协调改进以改善结局。
研究设计与样本
- 综述,讨论长期透析患者容量评估的现状、方法及未来方向。
主要发现
- 透析单位间容量相关实践差异大,临床决策隐含基于容量评估。
- 同位素稀释法不实用,可能并非肾衰竭患者的金标准。
- 体重与血压个体趋势被用作容量状态的实用替代指标。
- 基于血压探测目标体重仍广泛实践,但可能带来容量耗竭和残余肾功能加速丧失的风险。
- 颈静脉压升高和腿部水肿等临床体征诊断准确性差且观察者间变异大。
临床怎么用
- 可利用现有技术开展不同液体管理策略的比较效果研究。
- 应常规和标准化测量容积参数并纳入患者个体偏好。
- 需创新整合现有容量评估方法。
局限性
- 肺超声和生物电阻抗分析尚未在临床试验中证实改善临床结局。
- 临床体征诊断准确性差且观察者间变异大,限制其在临床试验中的可重复性。
- 其他容量评估技术需进一步临床试验评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accurate assessment of fluid status is a priority for patients with kidney failure undergoing long-term dialysis. There is wide variation in current volume-related practices between dialysis units and an urgent need to develop better evidence to guide practice. Clinical decisions relating to volume management are implicitly based on assessment of volume status, and there are numerous different but imperfect methods of assessment. Isotope-based dilutions are impractical for clinical use and may not be a gold standard for patients with kidney failure. Individual trends in body weight and BP have been used as a pragmatic surrogate marker for volume status. Probing the target weight based on BP is still widely practiced but may pose risks related to volume depletion and accelerated loss of residual kidney function. Clinical signs, such as elevated jugular venous pressure and leg edema, are readily accessible but have poor diagnostic accuracy and wide interobserver variability that limit their reproducibility for volume assessment in clinical trials. Lung ultrasound and bioelectrical impedance analysis have a sound scientific rationale for the assessment of extracellular volume and are appropriately associated with clinical outcomes, but neither approach has demonstrated convincingly favorable clinical outcomes in clinical trials. Other technologies for volume assessment exist but require further assessment in clinical trials. Advancements in clinical care can be made with existing technologies through comparative effectiveness trials of different fluid management strategies, routine and standardized measurement of volumetric parameters and individual patient preferences, and innovative integration of existing volume assessment methods. A systematic and globally coordinated approach to improving volume assessment and management is required to improve outcomes in patients receiving long-term dialysis.
引用
- Lazarus B, Davies SJ, Polkinghorne KR, et al. Volume Assessment in Patients Undergoing Long-Term Dialysis. J Am Soc Nephrol. 2025. PMID: 40193216. doi:10.1681/ASN.0000000724
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。